Intercontinental Exchange (NYSE: ICE) counsel sells thousands of shares under preset trading plan
Rhea-AI Filing Summary
Intercontinental Exchange, Inc. (ICE) reported that General Counsel Andrew J. Surdykowski exercised 2,065 stock options at an exercise price of $57.31 per share, converting them into an equal number of ICE common shares. On the same day, he sold an aggregate of 4,574 common shares in open-market transactions at prices ranging from $161.16 to $162.95, all pursuant to a Rule 10b5-1 trading plan that became effective November 25, 2025. The options exercised were fully vested, and a remaining option balance of 2,064 options is reported. Beneficial holdings also include 35,891 shares of common stock, 5,734 unvested RSUs, and 1,440 performance-based RSUs whose satisfaction and share issuance will be determined in future periods.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) Holding F8 | 2,065 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 2,065 | $57.31 | $118K |
| Sale | Common Stock F1, F3 | 3,974 | $161.6737 | $642K |
| Sale | Common Stock F1, F4, F5, F6, F7 | 600 | $162.3833 | $97K |
Footnotes (8)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
- F2. Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
- F3. The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F4. The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F5. The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
- F6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
- F7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- F8. These options are fully vested.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Employee Stock Option financial
restricted stock units ("RSUs") financial
performance based restricted stock units ("PSUs") financial
earnings before interest, taxes, depreciation, and amortization ("EBITDA") financial
Deal Incentive Awards financial
FAQ
What insider transactions did ICE General Counsel Andrew J. Surdykowski report on this Form 4 for ICE?
At what prices did Andrew J. Surdykowski sell ICE stock in this Form 4?
Were Andrew J. Surdykowski’s ICE stock sales under a Rule 10b5-1 plan?
What option exercise did Andrew J. Surdykowski report for ICE on this Form 4?
What ICE equity awards and holdings are reported for Andrew J. Surdykowski in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.